Relapsed B-ALL
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| The Predictability of CD19 Expression Across Primitive Cellular Fractions of Relapsed B-ALL on Outcomes of CD19-targeted CAR T-cells (NCT06993766) | King Faisal Specialist Hospital & Research Center | 2025-05-20 |
Track Relapsed B-ALL automatically
Every clearance here is in the API, with alerts when new ones post.